Gene and Cell Therapy | Ohio Life Sciences

Abeona Therapeutics, Inc.

Scott Gray — Mon, 03 Jul 2023 17:14:08 +0000

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. The company’s multi-platform expertise across the research, development, manufacture, and discovery of novel gene and cell therapies has it uniquely positioned to bring new medicines to patients in need.

AmplifyBio, LLC

Scott Gray — Sun, 02 Jul 2023 16:06:31 +0000

AmplifyBio is a preclinical contract research organization that will advance the quality of human health and save lives by creating next-generation platforms, tools, and services to amplify and accelerate the development of therapies and vaccines that will be accessible to millions of people.

Andelyn Biosciences, Inc.

Scott Gray — Sun, 02 Jul 2023 16:06:43 +0000

Andelyn Biosciences is a biopharmaceutical CDMO pioneering solutions that turn hope into reality. With 20+ years of experience manufacturing viral vectors, Andelyn’s scientific expertise for development and characterization has led to GMP material being produced for over 75+ worldwide clinical trials and 400+ cGMP clinical batches. Advanced quality systems, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of innovative therapies to bring more treatments to more patients.

Andelyn Biosciences, Inc. (Andelyn Corporate Center)

Scott Gray — Sun, 02 Jul 2023 16:06:45 +0000

The new Andelyn Corporate Center (ACC) clinical and commercial gene therapy manufacturing facility is ready to produce Gene Therapies. The ACC has 14 upstream rooms and the downstream and support rooms to meet the demanding needs of the gene therapy community. Each room is multiple modality and allows up to 90 Hyperstack production, Suspension in 200, 500, & 2000 L, iCELLis, and flexible for other platforms or technical transfer into Andelyn Biosciences. This is part of what makes Andelyn your trusted team in Gene Therapy manufacturing.

Armatus Bio, Inc.

Scott Gray — Sun, 02 Jul 2023 16:07:29 +0000

Armatus Bio is building a synergistic, multi-asset pipeline of next-generation candidates that offer disruptive new approaches to gene replacement, knockdown, and delivery. This allows us to target a range of diseases for communities with few or no therapeutics today. We believe we have the right tools to reach patients faster and more successfully than ever before.

Athersys, Inc.

Scott Gray — Sun, 02 Jul 2023 16:08:03 +0000

Athersys, Inc. is a developing biopharmaceutical company engaged in the discovery and development of therapeutics. MultiStem is a patented and proprietary stem cell treatment for multiple disease indications, and that is currently being evaluated in two ongoing clinical trials. In addition, Athersys is developing novel pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, narcolepsy or other forms of excessive daytime sleepiness, bone marrow transplant and stroke.

Celloram

Scott Gray — Fri, 13 Oct 2023 12:16:28 +0000

Celloram Inc. is a preclinical stage company founded in 2018. Our team of experienced leaders and scientists share a passion for improving the health and well-being of patients and families affected by cancer and chronic disease. Celloram has a deep sense of social responsibility. We are dedicated to the community in which we reside and work, and where we honor our commitment to promote diversity by inspiring, educating and developing the next generation of scientists and leaders.

Celloram now leverages its key discoveries to develop unique forms of cell therapy and small molecule therapeutics that harness our body’s own unique potential to heal and battle chronic illnesses including cancer, autoimmune disease, chronic inflammatory and metabolic disorders. Our mission and vision stem from our strong belief in the potential of new, less toxic therapies with the power to ignite our body’s self-healing process. Our mission is to inspire and develop transformative therapies that prevent disease and promote healing.

Convelo Therapeutics, Inc.

Scott Gray — Sun, 02 Jul 2023 16:14:59 +0000

Convelo Therapeutics is developing medicines to regenerate myelin around nerve cells and restoring function to patients with neurological disorders.

Dapcel, Inc.

Scott Gray — Sun, 02 Jul 2023 16:15:51 +0000

DAPCEL, Inc. is a research biotechnology company focused on the development of strategies for optimization of enhanced protein production in any desired host organism. To this end DAPCEL, Inc. utilizes unique approach for gene redesign. The approach takes into account the importance of rare codons and overall kinetics of protein translation guided by synonymous codon usage for protein folding and results in high yields of correctly folded soluble proteins.

DNA Nanobots, LLC

Scott Gray — Sun, 02 Jul 2023 16:17:01 +0000

DNA Nanobots is a passionate team of scientists and engineers dedicated to pushing the boundaries of DNA nanotechnology. We believe that with the right tools and expertise, we can unlock the potential of custom DNA nanostructures and create powerful solutions to some of humanity’s most pressing challenges. Our products make it easier than ever to assemble complex DNA nanobots with unprecedented precision. For the Targeted Delivery of small molecule chemotherapy, proteins, peptides, or genes, with our help, we can design, build, and help deploy your own custom DNA nanostructures in no time. We provide services as a drug delivery vehicle (or other payload) as we continue to develop our own products and pipeline.